Intramedullary Spine Disease by Bradley, William G.
UNIT A9.1Intramedullary Spine Disease
One of the most significant impacts of magnetic resonance (MR) has been its ability to
exquisitely depict normal and pathologic anatomy of the spine. Direct acquisitions
acquired in multiple planes coupled with the ability to study the spine with different T1-
and T2-weighted images have enabled critical assessment of the spinal cord and its
surroundings not previously available to the medical imaging specialist. The development
of contrast media has further extended the capability of MR imaging of the spinal cord
by improving its sensitivity and has allowed the use of the method in certain additional
types of pathology. The first protocol (see Basic Protocol) deals with intramedullary
disease, i.e., that involving the cord, the next one deals with extramedullary-intradural
disease. Both can cause myelopathy.
BASIC
PROTOCOL
MYELOPATHY
Our basic protocol consists of a sagittal T1-weighted conventional spin echo, a sagittal
T2-weighted fast spin echo, and a transverse T2*-weighted gradient echo. Most of the time
we will also add T1-weighted images in the sagittal and transverse planes before and after
administration of gadolinium. It is important that at least one pair of pre- and post-contrast
images be identical to facilitate detection of subtle enhancement. Thus, if fat saturation
is used following administration of contrast, it should also be used at least in one plane
prior to injection of contrast agent. At 1.5 T, we use a dose of 0.1 mmol/kg; on our low
field open magnet, we use 0.2 mmol/kg to get comparable enhancement. The reason for
this is that T1 increases with field strength so that, for a given TR of 500 msec, the low
field acquisition is actually less T1-weighted than a high field acquisition. Coupled to this
is the need for a longer TE to accommodate the longer echo sampling time required for a
lower bandwidth acquisition. The resultant increased T2-weighting competes with one’s
already marginal T1-weighted contrast—hence the need for double dose at lower field.
When the sensory level is fairly specific, we will limit the examination to the cervical or
thoracic spine; for most myelopathy workups; however, we do the complete spinal cord
from foramen magnum to conus. This can usually be accomplished in one acquisition
using phased array coils without loss of signal-to-noise. The cervical and thoracic portions
are then magnified and filmed (or viewed) separately. While we always acquire transverse
images through the cervical spine, we generally only acquire transverse images at the
level of a suspected abnormality in the thoracic cord.
Table A9.1.1 lists the hardware necessary to perform the procedure. Subsequent tables
list imaging parameters appropriate for high field—i.e., 1.0 to 1.5 T. For lower fields, the
echo times (i.e., TE) are generally increased to accommodate lower bandwidths and the
number of acquisitions (Nacq) is generally doubled.
This protocol takes about 30 min from start to finish.
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Table A9.1.1 Equipment Parameters
Coil type Circularly polarized (quadrature) neck coil and/or
torso phased array coil
Cardiac gating No
Peripheral gating For safety only
Respiratory gating No
Respirator If required by patient
Oxygen If required by patient
Motion cushions Useful
Use of contrast agents Yes
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Materials
Normal saline (0.9% NaCl; 500-ml bag)
K-50 tubing
23- to 25-G butterfly needle
Intravenous MRI contrast agent (e.g., Magnevist, Omniscan, Prohance, or
OptiMark at a dose of 0.1 mmol/kg for high field or 0.2 mmol/kg for low field).
NOTE: Be sure that technicians and nurses always have immediate access to any
emergency equipment that may be relevant to a given study, or that may be needed for a
particular patient—i.e., crash carts and oxygen.
Set up equipment and patient
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or other implants containing ferromagnetic materials. Also be
sure to find out if the patient has any health conditions that may require the presence
of special emergency equipment during the scanning procedure, or necessitate any
other precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet and how to behave, including the following.
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but other motion should be avoided when comparative positional studies
are being performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
5. Help the patient mount onto the table. Either before or right after the patient lies down,
set up any triggering devices or other monitoring equipment that is to be used.
6. Center the coil over the region of the spine where the key information is desired.
Make sure that the body is constrained to prevent motion, especially if high resolution
scans are to be run.
Current Protocols in Magnetic Resonance Imaging
A9.1.2
Intramedullary
Spine Disease
7. If intravenous gadolinium or i.v. sedation will be given, start an i.v. line and attach it
securely to the patient so that movement into or out of the magnet will not pull at the
patient’s arm. Hang a bag of saline and adjust drip to keep it open.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion, between the scans run before contrast agent injection and those
run after injection.
8. If needed, place a pillow or other support under the head and knees to make the patient
more comfortable.
9. Use the centering light to position the patient (Table A9.1.2) at the threshold of the
magnet and then put him or her into the center of the magnet.
Once this step has been performed, so long as the patient does not move on the table, the
table itself can be moved and then replaced in the same position as before without
jeopardizing the positioning of one scan relative to another.
10. If the patient is unable to hold still, provide an appropriate sedative; if the patient is
in pain, provide an appropriate analgesic.
Sequence 1: Rapid positioning pilot (Fig. A9.1.1)
11. To verify patient position, run the pilot (or scout) scan to ensure correct location of
the neck or back in three dimensions, using the imaging sequence given in Table
A9.1.2 or similar parameters.
This sequence usually consists of three orthogonal planes to allow subsequent localization.
The images are often also used later to determine where to place the saturation pulses and
to set up coverage of the volume of interest.
Sequence 2: Sagittal T1-weighted conventional spin echo (Fig. A9.1.2)
12. Set the imaging parameters as shown in Table A9.1.3.
13. Use the pilot image to locate the spine in three dimensions to ensure coverage of the
region of interest (e.g., cervical, thoracic, lumbosacral spine).
14. Tell the patient (through the speaker system) that you are ready to begin the scan.
Table A9.1.2 Primary Clinical Imaging Parameters for Pilot Scan (Sequence 1)
Patient position Supine
Scan type Gradient Echo
Imaging plane (orientation) Transverse, sagittal, coronal
Central slice or volume center Cervical: on thyroid cartilage
Thoracic: on sternal notch
Echo time (TE) As short as possible
Repeat time (TR) As short as possible
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) Cervical: 280 mm, 280 mm
Thoracic: 350 mm, 350 mm
Resolution (∆x, ∆y) Cervical 1.09 mm, 2.19 mm
Thoracic: 1.37 mm, 2.73 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 5 in each plane
Slice gap 1 mm
Number of acquisitions (Nacq) 1
Scan time 30 sec (all 3 planes)
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Sequence 3: Sagittal T2-weighted fast spin echo (FSE) (Fig. A9.1.3)
15. Review the pilot scans and ensure the saturation pulses are correctly placed anterior
to or above the slab of interest.
16. Run sequence 3 according to Table A9.1.4.
Sequence 4: Transverse T2*-weighted gradient echo (Fig. A9.1.4)
17. Using the midline sagittal T1-weighted image acquired in sequence 2 as a localizer:
a. Cervical spine: acquired stacked images from C1 through T1.
b. Thoracic spine: acquire single or stacked images through the levels of interest.
c. Supplement with additional slices according to visible disease present or to clinical
query.
18. Run sequence 4 according to Table A9.1.5.
A B
C
Figure A9.1.1 Scout images (A) transverse, (B) coronal, and (C) sagittal.
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Table A9.1.3 Primary Clinical Imaging Parameters for T1-Weighted Spin Echo
(Sequence 2)
Patient position Supine
Scan type Conventional spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slice centered on:
Cervical: the third cervical
vertebra
Thoracic: the 6th thoracic vertebra
Echo time (TE) 14 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) Cervical: 260 mm, 260 mm
Thoracic: 320 mm, 320 mm (may
use rectangular field of view [e.g.,
half or three-quarter field] if
available, or tailor to region of
interest)
Resolution (∆x, ∆y) Cervical: 1.02 mm, 1.02 mm
Thoracic: 1.25 mm, 1.25 mm
Number of data points collected (Nx, Ny) 256, 256
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 12
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Flow compensation Yes (if available)
Saturation pulses Superior, inferior, anterior
Scan time 3 min, 20 sec
Figure A9.1.2 Sagittal T1-weighted spin echo image.
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Table A9.1.4 Primary Clinical Imaging Parameters for T2-Weighted FSE
(Sequence 3)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Centered on area of interest (as in
sequence 2, Table A9.1.3)
Echo time (TE) 102 msec
Echo train length (ETL) 8
Repeat time (TR) 4000 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) As in sequence 2, Table A9.1.3
Resolution (∆x, ∆y) As in sequence 2, Table A9.1.3
Number of data points collected (Nx, Ny) 256, 256
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 3 mm
Number of slices 12
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Flow compensation Yes (if available)
Saturation pulses Superior, inferior, anterior
Scan time 3 min, 12 sec
Figure A9.1.3 Sagittal T2-weighted fast spin echo image.
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Table A9.1.5 Primary Clinical Imaging Parameters for T2*-Weighted Gradient
Echo (Sequence 4)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Volume centered on the area of
interest (as in sequence 2, Table
A9.1.3)
Echo time (TE) 16 msec
Repeat time (TR) 35 msec
Flip angle (FA) 5°
Fields of view (FOVx, FOVy) 220 mm, 220 mm
Resolution (∆x, ∆y) 0.86 mm, 0.86 mm
Number of data points collected (Nx, Ny) 256, 256
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 2-3 mma
Number of slices 36
Slice gap 0
Number of acquisitions (Nacq) 1
Flow compensation Yes (if available)
Saturation pulses No
Scan time 5 min, 26 sec
aIf 3 mm, zero interpolate (ZIP) to 1.5 mm.
Figure A9.1.4 Transverse T2*-weighted gradient echo image.
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Sequence 5: Transverse T1-weighted conventional spin echo (Fig. A9.1.5)
19. Using the midline T1-weighted image acquired in sequence 2 as a localizer, position
slices as in step 17 and run sequence 5 according to Table A9.1.6.
Sequences 6 and 7: Post contrast sequences (Fig. A9.1.6)
20. Leaving the patient unchanged in position in the magnet, inject the contrast agent,
flush the line with 10 ml saline, and then immediately run “post contrast” sagittal
Table A9.1.6 Primary Clinical Imaging Parameters for T1-Weighted Spin Echo
(Sequence 5)
Patient position Supine
Scan type Conventional spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Centered on the area of interest
(as in sequence 2, Table A9.1.3)
Echo time (TE) 16 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 23
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Flow compensation Yes (if available)
Saturation pulses Superior, inferior
Scan time 5 min, 25 sec
Figure A9.1.5 Transverse T1-weighted spin echo image.
Current Protocols in Magnetic Resonance Imaging
A9.1.8
Intramedullary
Spine Disease
(sequence 6) and transverse (sequence 7) T1-weighted image sequences (using the
parameters in Tables A9.1.3 and A9.1.6, respectively).
ALTERNATE
PROTOCOL
TRAUMA
For trauma cases, the most important reason for the examination is to determine if there
has been cord hemorrhage. This is best detected using T2*-weighted gradient echo images.
For the trauma protocol, a sagittal T2*-weighted sequence is added (Table A9.1.7) and the
enhanced sequences 6 and 7 are dropped.
Table A9.1.7 Primary Clinical Imaging Parameters for T2*-Weighted Gradient
Echo (Sequence 8)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Slice centered on area of interest
(as in sequence 2, Table A9.1.3)
Echo time (TE) 20 msec
Repeat time (TR) 450 msec
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 260 mm, 260 mm
Resolution (∆x, ∆y) 1.02 mm, 1.35 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 4 mm
Number of slices 12
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Flow compensation Yes (if available)
Saturation pulses Superior, inferior, anterior
Scan time 4 min, 32 sec
A B
Figure A9.1.6 Post-contrast T1-weighted spin echo images: (A) sagittal and (B) transverse. 
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Set up equipment and patient
1. Repeat steps 1 to 19 in the Basic Protocol.
Sequence 8: Sagittal T2*-weighted gradient echo
2. Run sequence 8 according to Table A9.1.7.
COMMENTARY
Background Information
Just as the gadolinium chelates have proven
useful in MR imaging of the brain, the same is
true of the spinal cord (Haughton et al., 1999;
Najem et al., 1999). Intramedullary tumors and
inflammatory processes which are perfused
and which have blood-cord barrier breakdown
enhance with gadolinium. The most common
cord tumor is the glioma of which there are two
primary types: astrocytoma and ependymoma
(Haughton et al., 1999; Najem et al., 1999).
Astrocytomas tend to occur higher in the cord
than ependymomas, often involving the cervi-
cal region or even extensive portions of the
cervical and thoracic cord. They are infiltrative
lesions which are difficult to resect surgically
and respond poorly to radiation therapy. Epen-
dymomas tend to occur lower in the cord, near
the conus medullaris, and are generally better
behaved than astrocytomas. Specifically, they
are more easily removed surgically and tend to
have a more favorable response to radiotherapy.
As with other processes in the cord, it is impor-
tant to define the upper and lower extent of
disease. In the case of ependymomas, it is
particularly important to image the entire neu-
raxis as the tumor can seed through the cere-
brospinal fluid (CSF) spaces throughout the
spinal and intracranial subarachnoid spaces
(Haughton et al., 1999; Najem et al., 1999).
Acute tumefactive multiple sclerosis (MS)
can simulate a cord tumor. Often, the key to the
diagnosis is not the additional administration
of gadolinium to the cord lesion but rather an
additional MRI of the brain to search for
periventricular lesions. We have found thin
slice, sagittal, fast FLAIR (fluid attenuated in-
version recovery) to be particularly useful for
this assessment (Hashemi et al., 1995; Palmer
et al., 1999). In the absence of intracranial
findings, tumefactive MS may not be distin-
guishable from cord tumor, either on the basis
of enhancement features or lack of same. In
such cases, it is useful to rescan the patient in
6 or 12 weeks, as acute tumefactive MS tends
to resolve over this period of time while a tumor
would tend to remain unchanged in size or to
grow.
While MS is, by definition, a relapsing dis-
ease, it may be difficult to make the diagnosis
definitively on the basis of the initial presenta-
tion. Similarly, it may be difficult to distinguish
the initial presentation of MS from another
demyelinating process such as ADEM (acute
disseminated encephalomyelitis). ADEM is a
monophasic demyelinating process which is
typically found in children and young adults
following an exanthematous viral infection or
vaccination. It is an autoimmune reaction to the
patient’s own white matter and can involve
either the brain or the spinal cord. It tends to
produce somewhat larger lesions than those
seen with multiple sclerosis. Since it is im-
mune-mediated, ADEM responds to steroids.
Syringohydromyelia is a difficult diagnosis
to make by myelography as the overall cord
contour may not be enlarged (Haughton et al.,
1999; Najem et al., 1999). Delayed post-myelo-
gram CT (computed tomography) has been
useful in demonstrating diffusion of contrast
material into the central cavity; however, it is
much less sensitive than MRI. When a syrinx
is identified on an MR study, its upper and lower
margins should be identified. The foramen
magnum should be evaluated for the presence
of low-positioned cerebellar tonsils, as a Chiari
I malformation is often associated with a syr-
inx. Actually, since this form of syrinx is really
enlargement of the ependyma-lined central ca-
nal, the more proper term is “hydromyelia”. If
a syrinx is found without a Chiari I malforma-
tion, then gadolinium should be given, as syr-
inges are often found in association with cord
tumors. These tumors can be cranial or caudad
to the syrinx and can be intra- or extramedullary
(Haughton et al., 1999; Najem et al., 1999).
They are thought to arise from the obstruction
of flow of CSF between the central canal and
the subarachnoid space via the perivascular
spaces of the cord (Fischbein et al., 1999).
Hemangioblastomas are highly vascular tu-
mors which can not only produce a syrinx but
also form a tumor cyst within the cord. When
a hemangioblastoma is found within the cord,
the cerebellum should also be evaluated as
asymptomatic lesions may be harbored there as
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well. When found in both locations, the patient
may have von Hippel-Lindau disease.
Trauma can injure the spinal cord through
compression from posterior buckling of the
posterior longitudinal ligament or frank
retropulsion of a fractured vertebral body into
the canal (Davis et al., 1991). The key MR
finding in spinal trauma is cord hemorrhage.
Since hemorrhage may either be identified on
the basis of a short T1 or a short T2, both
T1-weighted spin echo and T2*-weighted gradi-
ent echo images should be performed. (T2-
weighted spin echo images tend to be prone to
motion artifact and the commonly used T2-
weighted fast spin echo sequences tend to mini-
mize susceptibility effects and the detection of
short T2 hemorrhage.) Cord edema without
hemorrhage (i.e., a “bland contusion”) tends to
resolve with minimal (if any) neurologic defi-
cits, while hemorrhagic contusions tend to be
associated with more serious disability. In the
acute or subacute setting, it is also important to
exclude persistent causes of cord compression
(i.e., extruded fragments or retropulsed bony
fragments), which may have been overlooked
on plain films or CT. The late sequellae of
trauma include myelomalacia (gliosis of the
cord), cystic myelomalacia, and frank syrinx
formation. In the extreme, cord transection can
be easily diagnosed by MR.
MR is useful for diagnosing vascular mal-
formations of the cord of which there are three
types: intramedullary arteriovenous malforma-
tions (AVMs), extramedullary (radiculomen-
ingeal or dural) AVMs, and cavernous
angiomas (Haughton et al., 1999; Najem et al.,
1999). As in the brain, cavernous angiomas
generally appear as areas of low signal on
T2-weighted images (due to hemosiderin). In
institutions where the bright CSF, low flip an-
gle, gradient echo technique has been replaced
by a T2-weighted fast spin echo, these magnetic
susceptibility effects may be less obvious (as
noted above). True AVMs of the cord (i.e., nidus
within cord parenchyma) are unusual. Radicu-
lomedullary vascular malformations of the
dura and radicular vessels are more common.
These may produce scalloping of the protein
cord margins. The flow void produced by these
enlarged vessels in the subarachnoid space
must be distinguished from the normal CSF
flow voids noted particularly posterior to the
cord. High cord signal on T2-weighted images
distal to the AVM may represent ischemia sec-
ondary to a vascular steal phenomenon.
Critical Parameters and
Troubleshooting
The most common problem with spine im-
aging is CSF motion artifacts. These can simu-
late vascular flow voids, giving the appearance
of arteriovenous malformations, particularly
on bright CSF gradient echo acquisitions (e.g.,
Table A9.1.5 and Table A9.1.7). In such cases,
T2-weighted fast spin echo imaging has been
shown to have particular utility due to the natu-
ral flow compensation inherent in the multiple
180° pulses. Increasing the bandwidth to lower
the echo spacing and decreasing the time avail-
able for motion dephasing is another trick to
decrease these motion artifacts.
Swapping phase encoding and read direc-
tions such that the phase encoding direction is
craniocaudad rather than anterior-posterior
also serves to minimize CSF motion artifacts
overlying the cord which could potentially
simulate syringohydromyelia.
Patients with severe back pain should be
appropriately medicated with morphine or
Demerol (rather than merely given sedation) to
be able to lie motionless for their study.
Anticipated Results
MRI of the cord should demonstrate abnor-
mal signal intensity corresponding to clinical
symptoms. These symptoms should correlate
with the location of the tracts with the cord.
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